{"id":458570,"date":"2026-01-20T00:30:00","date_gmt":"2026-01-19T23:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=458570"},"modified":"2026-01-19T22:52:51","modified_gmt":"2026-01-19T21:52:51","slug":"fremanezumab-per-lemicrania-e-la-depressione-in-comorbilita","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/fremanezumab-per-lemicrania-e-la-depressione-in-comorbilita\/","title":{"rendered":"Fremanezumab per l&#8217;emicrania e la depressione in comorbilit\u00e0"},"content":{"rendered":"\n<p><strong>L&#8217;emicrania e la depressione spesso si rafforzano a vicenda e rendono pi\u00f9 difficile il trattamento. Lo studio UNITE dimostra che l&#8217;anticorpo CGRP fremanezumab riduce in modo significativo sia i giorni di emicrania che i sintomi depressivi, anche nei pazienti con una terapia complessa precedente. Il farmaco si \u00e8 dimostrato efficace, ben tollerato e potenzialmente doppiamente benefico.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Ffremanezumab-per-lemicrania-e-la-depressione-in-comorbilita%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;emicrania e la depressione spesso si rafforzano a vicenda e rendono pi\u00f9 difficile il trattamento. Lo studio UNITE dimostra che l&#8217;anticorpo CGRP fremanezumab riduce in modo significativo sia i giorni&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Ffremanezumab-per-lemicrania-e-la-depressione-in-comorbilita%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":458571,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Emicrania","footnotes":""},"category":[11452,11371,11550,11515],"tags":[67243,19781,14677,13884,28712],"powerkit_post_featured":[],"class_list":["post-458570","post","type-post","status-publish","format-standard","has-post-thumbnail","category-farmacologia-e-tossicologia","category-neurologia-it","category-rx-it","category-studi","tag-anticorpi-cgrp","tag-cgrp-it","tag-depressione","tag-emicrania","tag-fremanezumab-it","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-27 03:07:22","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":458563,"slug":"fremanezumab-para-a-enxaqueca-e-depressao-comorbidas","post_title":"Fremanezumab para a enxaqueca e depress\u00e3o com\u00f3rbidas","href":"https:\/\/medizinonline.com\/pt-pt\/fremanezumab-para-a-enxaqueca-e-depressao-comorbidas\/"},"es_ES":{"locale":"es_ES","id":458663,"slug":"fremanezumab-para-la-migrana-comorbida-y-la-depresion","post_title":"Fremanezumab para la migra\u00f1a com\u00f3rbida y la depresi\u00f3n","href":"https:\/\/medizinonline.com\/es\/fremanezumab-para-la-migrana-comorbida-y-la-depresion\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/458570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=458570"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/458570\/revisions"}],"predecessor-version":[{"id":458573,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/458570\/revisions\/458573"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/458571"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=458570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=458570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=458570"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=458570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}